- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04142853
Underlying Causes and Related Factors, and Rehabilitation Approaches
Walking-related Performance Fatigabitity in People With Multiple Sclerosis: Clinical Profile o
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Hasselt, Belgium, 3500
- Hasselt University
-
Liège, Belgium, 4000
- Centre Hospitalier Universitaire de Liege
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age between 18 and 70 years.
- MS diagnosis according to McDonald Criteria.
- Capable of walking 6 minutes (independent or with unilateral support) without stopping.
Exclusion Criteria:
- Exacerbation or relapse within last 3 months before study
- Other medical condition interfering with walking ability (e.g. cardiac or respiratory diseases, arthritis and fibromyalgia, stroke, Parkinson).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Persons with MS, dance group
|
Training intervention + Dance intervention
|
Active Comparator: Persons with MS, art group
|
Training intervention + Dance intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the Symbol Digit Modality Test (SDMT) (Cognitive fatigability)
Time Frame: week 11
|
his is a cognitive performance test, substantiated with focus, speed, and visual scanning.
Correct answers last 30 seconds vs first 30 seconds
|
week 11
|
Nine Hole Peg Test (NHPT)
Time Frame: week 11
|
This is a motor test to assess the participant's manual skills.
This test records the time the participant needs to place 9 pins in the pegboard and remove them again.
|
week 11
|
the Coordination test
Time Frame: Day 1
|
Participant is seated with legs strapped in to the mounts and moves legs to the beat of a metronome to assess central motor control.
|
Day 1
|
TST (Triple Stimulation Technique)
Time Frame: day 3
|
Technique in which nerves are stimulated to check guidance in the central nervous system
|
day 3
|
TMS (Transcranial Magnetic Stimulation)
Time Frame: Day 3
|
Technique in which nerves are stimulated to check guidance in the central nervous system
|
Day 3
|
the Voluntary Drive test
Time Frame: Day 1
|
The participant is seated in a Biodex.
While performing a leg extension the Quadriceps muscle is stimulated to check the guidance of electrical signals to the muscles.
|
Day 1
|
the Fatigability Index Legs
Time Frame: Day 1
|
Participant is seated in a Biodex and a protocol is performed to establish the muscle strength and muscle endurance of the legs.
|
Day 1
|
Analysis of a Muscle Biopsy
Time Frame: Day 3
|
A small piece of muscle tissue of the weakest leg will be biopsied and analyzed in the lab.
|
Day 3
|
the Digit Span
Time Frame: Baseline
|
Cognitive test where numbers must be recalled in a certain order to evaluate short term memory
|
Baseline
|
the Digit Span
Time Frame: Week 11
|
Cognitive test where numbers must be recalled in a certain order to evaluate short term memory
|
Week 11
|
the Stroop test
Time Frame: Baseline
|
Cognitive test to evaluate attention and simultaneous processing of multiple stimuli.
|
Baseline
|
the Stroop test
Time Frame: week 11
|
Cognitive test to evaluate attention and simultaneous processing of multiple stimuli.
|
week 11
|
the Paced Auditory Serial Addition Test (PASAT)
Time Frame: Baseline
|
This is a cognitive test where the participant will try to retain certain numbers they hear and do math.
Correct answer last 1/3 vs first 1/3
|
Baseline
|
the Paced Auditory Serial Addition Test (PASAT)
Time Frame: Week 11
|
This is a cognitive test where the participant will try to retain certain numbers they hear and do math.
Correct answer last 1/3 vs first 1/3
|
Week 11
|
the Symbol Digit Modality Test (SDMT) (Cognitive fatigability)
Time Frame: Baseline
|
his is a cognitive performance test, substantiated with focus, speed, and visual scanning.
Correct answers last 30 seconds vs first 30 seconds
|
Baseline
|
Motor function test (lower limb muscle strength)
Time Frame: Baseline
|
This is a motor test to assess the functional lower limb muscle strength.
The participant is asked to stand from a seated position and sit down again as fast as possible for five times in a row.
|
Baseline
|
Motor function test (lower limb muscle strength)
Time Frame: week 11
|
This is a motor test to assess the functional lower limb muscle strength.
The participant is asked to stand from a seated position and sit down again as fast as possible for five times in a row.
|
week 11
|
25 Foot Walk (T25FW) test
Time Frame: Baseline
|
his is a motor test at which the participant is instructed to walk 25 ft (=7,62 meter) as fast and safely as possible.
This is a quantitative performance test to assess mobility and leg function.
|
Baseline
|
25 Foot Walk (T25FW) test
Time Frame: week 11
|
his is a motor test at which the participant is instructed to walk 25 ft (=7,62 meter) as fast and safely as possible.
This is a quantitative performance test to assess mobility and leg function.
|
week 11
|
Nine Hole Peg Test (NHPT)
Time Frame: Baseline
|
This is a motor test to assess the participant's manual skills.
This test records the time the participant needs to place 9 pins in the pegboard and remove them again.
|
Baseline
|
Fatigability Index Hand
Time Frame: Baseline
|
Grip strength will be evaluated through a Jamar dynamometer.
|
Baseline
|
Fatigability Index Hand
Time Frame: week 11
|
Grip strength will be evaluated through a Jamar dynamometer.
|
week 11
|
Activity tracker
Time Frame: Up to 5 days
|
A sensor will be placed around the foot and worn by the participant for 5 days and nights to evaluate physical activity and quality of sleep.
|
Up to 5 days
|
Glycocheck
Time Frame: Baseline
|
A small camera will be placed under the tongue of the participant and blood vessels will be filmed to determine the quality of the blood vessels and immunity.
|
Baseline
|
Six minute walking test
Time Frame: once during the observational study
|
Participant have to walk as far as they can for 6 minutes.
Total distance walked and fatigability by comparing first and last minute distance will be calculated.
|
once during the observational study
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fatigue severity scale (FSS)
Time Frame: baseline
|
A self-report scale of nine items about fatigue, its severity and how it affects certain activities.
Answers are scored on a seven point scale where 1 = strongly disagree and 7 = strongly agree.
This means the minimum score possible is nine and the highest is 63.
The higher the score, the more severe the fatigue is and the more it affects the person's activities.
It is simple to understand and takes an average of eight minutes to answer
|
baseline
|
Fatigue severity scale (FSS)
Time Frame: week 11
|
A self-report scale of nine items about fatigue, its severity and how it affects certain activities.
Answers are scored on a seven point scale where 1 = strongly disagree and 7 = strongly agree.
This means the minimum score possible is nine and the highest is 63.
The higher the score, the more severe the fatigue is and the more it affects the person's activities.
It is simple to understand and takes an average of eight minutes to answer
|
week 11
|
Modified Fatigue Impact Scale (MFIS)
Time Frame: baseline
|
This is a short questionnaire to evaluate to impact of general fatigue.
This questionnaire measures the effects of fatigue on three levels: physical, cognitive and psychosocial.
The MFIS is a 21-item questionaire, scale 0 (never)-4 (always), scale range 0-40
|
baseline
|
Modified Fatigue Impact Scale (MFIS)
Time Frame: week 11
|
This is a short questionnaire to evaluate to impact of general fatigue.
This questionnaire measures the effects of fatigue on three levels: physical, cognitive and psychosocial.The MFIS is a 21-item questionaire, scale 0 (never)-4 (always), scale range 0-40
|
week 11
|
Fatigue Scale of Motor and Cognitive Functions (FSMC)
Time Frame: baseline
|
This is a short questionnaire to cognitive and motor fatigue in people with MS.
The FSMC is an assessment of MS-related cognitive and motor fatigue.
A Likert-type 5-point scale (ranging from 'does not apply at all' to 'applies completely') produces a score between 1 and 5 for each scored question.
Thus minimum value is 20 (no fatigue at all) and maximum value is 100 (severest grade of fatigue).
Two subscales (mental and physical fatigue) can be made.
Items included in the subscale mental are 1-4-7-8-11-13-15-17-18-20 and items included in the subscale physical are 2-3-5-6-9-10-12-14-16-19.
|
baseline
|
Fatigue Scale of Motor and Cognitive Functions (FSMC)
Time Frame: week 11
|
This is a short questionnaire to cognitive and motor fatigue in people with MS.
The FSMC is an assessment of MS-related cognitive and motor fatigue.
A Likert-type 5-point scale (ranging from 'does not apply at all' to 'applies completely') produces a score between 1 and 5 for each scored question.
Thus minimum value is 20 (no fatigue at all) and maximum value is 100 (severest grade of fatigue).
Two subscales (mental and physical fatigue) can be made.
Items included in the subscale mental are 1-4-7-8-11-13-15-17-18-20 and items included in the subscale physical are 2-3-5-6-9-10-12-14-16-19.
|
week 11
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: baseline
|
This is a short questionnaire that evaluates symptoms of anxiety and depression in daily life.
Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression..
|
baseline
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: Week 11
|
This is a short questionnaire that evaluates symptoms of anxiety and depression in daily life.
Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression.
|
Week 11
|
The Sleep Condition Indicator (SCI)
Time Frame: baseline
|
This is a short questionnaire to evaluate sleeping pattern and potential sleeping disorders.
The Sleep Condition Indicator (SCI) is an eight-item rating scale (4-0) that was developed to screen for insomnia disorder based on DSM-5 criteria.
|
baseline
|
The Sleep Condition Indicator (SCI)
Time Frame: week 11
|
This is a short questionnaire to evaluate sleeping pattern and potential sleeping disorders.
The Sleep Condition Indicator (SCI) is an eight-item rating scale (4-0) that was developed to screen for insomnia disorder based on DSM-5 criteria.
|
week 11
|
Social Role Participation Questionnaire (SRPQ)
Time Frame: baseline
|
This is a short questionnaire to evaluate social participation.
scale 1 (not important) - 5(very important)
|
baseline
|
Social Role Participation Questionnaire (SRPQ)
Time Frame: week 11
|
This is a short questionnaire to evaluate social participation.
scale 1 (not important) - 5 (very important)
|
week 11
|
pre-interventionMSWS-12 score
Time Frame: baseline
|
short questionnaire to map out walking difficulties in daily living. The Multiple Sclerosis Walking Scale is a self-assessment scale which measures the impact of MS on walking. It consists of 12 questions concerning the limitations to walking due to MS during the past 2 weeks. Each item can be answered with 5 options, with 1 meaning no limitation and 5 extreme limitation. A total score can be generated and transformed to a 0 to 100 scale by subtracting the minimum score possible (12) from the patient's score, dividing by the maximum score possible minus the minimum possible (60-12 or 48), and multiplying the result by 100. Walking improvement on the MSWS-12 is indicated by negative change scores. |
baseline
|
post-interventionMSWS-12 score
Time Frame: baseline
|
short questionnaire to map out walking difficulties in daily living. The Multiple Sclerosis Walking Scale is a self-assessment scale which measures the impact of MS on walking. It consists of 12 questions concerning the limitations to walking due to MS during the past 2 weeks. Each item can be answered with 5 options, with 1 meaning no limitation and 5 extreme limitation. A total score can be generated and transformed to a 0 to 100 scale by subtracting the minimum score possible (12) from the patient's score, dividing by the maximum score possible minus the minimum possible (60-12 or 48), and multiplying the result by 100. Walking improvement on the MSWS-12 is indicated by negative change scores. |
baseline
|
pre-interventionMSWS-12 score
Time Frame: week 11
|
short questionnaire to map out walking difficulties in daily living. The Multiple Sclerosis Walking Scale is a self-assessment scale which measures the impact of MS on walking. It consists of 12 questions concerning the limitations to walking due to MS during the past 2 weeks. Each item can be answered with 5 options, with 1 meaning no limitation and 5 extreme limitation. A total score can be generated and transformed to a 0 to 100 scale by subtracting the minimum score possible (12) from the patient's score, dividing by the maximum score possible minus the minimum possible (60-12 or 48), and multiplying the result by 100. Walking improvement on the MSWS-12 is indicated by negative change scores. |
week 11
|
post-interventionMSWS-12 score
Time Frame: week 11
|
short questionnaire to map out walking difficulties in daily living. The Multiple Sclerosis Walking Scale is a self-assessment scale which measures the impact of MS on walking. It consists of 12 questions concerning the limitations to walking due to MS during the past 2 weeks. Each item can be answered with 5 options, with 1 meaning no limitation and 5 extreme limitation. A total score can be generated and transformed to a 0 to 100 scale by subtracting the minimum score possible (12) from the patient's score, dividing by the maximum score possible minus the minimum possible (60-12 or 48), and multiplying the result by 100. Walking improvement on the MSWS-12 is indicated by negative change scores. |
week 11
|
Multiple Sclerosis Impact Scale (MSIS-29)
Time Frame: Baseline
|
This is a short self-report questionnaire used to assess the day-to-day life in the past two weeks. This questionnaire has a physical and psychological scale. The MSIS-29 is a 29-item self-report measure with 20 items associated with a physical scale and 9 items with a psychological scale. Items ask about the impact of MS on day-to-day life in the past two weeks. All items have 5 response options: 1 "not at all" to 5"extremely". Each of the two scales are scored by summing the responses across items, then converting to a 0-100 scale where 100 indicates greater impact of disease on daily function (worse health). The physical impact score is computed by summing items number 1-20 inclusive. This score can then be transformed to a score on a scale of 0 -100 |
Baseline
|
Multiple Sclerosis Impact Scale (MSIS-29)
Time Frame: week 11
|
This is a short self-report questionnaire used to assess the day-to-day life in the past two weeks. This questionnaire has a physical and psychological scale. The MSIS-29 is a 29-item self-report measure with 20 items associated with a physical scale and 9 items with a psychological scale. Items ask about the impact of MS on day-to-day life in the past two weeks. All items have 5 response options: 1 "not at all" to 5"extremely". Each of the two scales are scored by summing the responses across items, then converting to a 0-100 scale where 100 indicates greater impact of disease on daily function (worse health). The physical impact score is computed by summing items number 1-20 inclusive. This score can then be transformed to a score on a scale of 0 -100 |
week 11
|
Short Form Health survey (SF-36)
Time Frame: Baseline
|
questionnaire to measure health status.
The Optum® SF-36v2® Health Survey asks 36 questions to measure functional health and well-being from the patient's point of view.
It is a practical, reliable and valid measure of physical and mental health that can be completed in five to ten minutes.
|
Baseline
|
Short Form Health survey (SF-36)
Time Frame: week 11
|
questionnaire to measure health status.
The Optum® SF-36v2® Health Survey asks 36 questions to measure functional health and well-being from the patient's point of view.
It is a practical, reliable and valid measure of physical and mental health that can be completed in five to ten minutes.
|
week 11
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B707201835771
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsRecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
University of California, San FranciscoUnited States Department of DefenseRecruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis (MS) | Multiple Sclerosis Relapse | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis Brain Lesion | Multiple Sclerosis BenignUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on Training intervention + Dance intervention
-
Wan-Yun HuangKaohsiung Veterans General Hospital.; National Cheng Kung UniversityCompletedVirtual Reality | Physical FitnessTaiwan
-
Karadeniz Technical UniversityCompletedStroke | Quality of Life | Cognitive ImpairmentTurkey
-
Federal University of Rio Grande do SulCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; University of...CompletedParkinson Disease(PD)Brazil, United Kingdom
-
Region Örebro CountyÖrebro University, SwedenActive, not recruitingFunctional Abdominal Pain | IBSSweden
-
Region Örebro CountyVärmland County Council, Sweden; Region Östergötland; Region GävleborgCompletedQuality of Life | Stress | Pain, Chronic | SpasticSweden
-
National University, SingaporeLion BefriendersActive, not recruiting
-
North Essex Partnership NHS Foundation TrustUniversity College, London; West Essex Clinical Commissioning Group; School for...CompletedStroke | Diabetes Mellitus | Dementia | Mild Cognitive Impairment | Cardiac DiseasesUnited Kingdom
-
University Health Network, TorontoHeart and Stroke Foundation of CanadaUnknown